Teva Pharmaceutical Industries is a global pharmaceutical company that develops, produces, and markets affordable generic and specialty medicines, with a leading position in generic drugs and a growing specialty portfolio focused on central nervous system disorders, immunology, and respiratory conditions.
Company Info
Upcoming Milestones & Key Dates
Q1 2026 Earnings — Austedo franchise and generic pipeline update
Expected close of API unit divestiture (subject to finding buyer)
Clinical Development Pipeline
Recent News
Teva's CEO said the company has time to prepare for the incoming tariffs on generic drugs manufactured outside the U.S., expressing confidence in its ability to brace for the impact.
Teva Pharmaceutical Industries is laying off approximately 250 employees at its active pharmaceutical ingredient (API) manufacturing unit, which the company is seeking to divest as part of an ongoing restructuring.
Leadership Team
Careers & Job Openings